Our stock is traded on the Nasdaq under the symbol NRXP.
Our public warrants are traded on the Nasdaq under the symbol NRXPW.
The Company was incorporated on September 18, 2017, as Big Rock Partners Acquisition Corp. (“BRPA”) and became a public company on November 17, 2017. Upon the reverse merger of a wholly owned subsidiary of BRPA and NeuroRx, Inc., BRPA changed its name to NRx Pharmaceuticals, Inc. The Company’s subsidiary, NeuroRx Inc., was incorporated on May 20, 2015.
The Company’s registered address is 1201 Orange Street, Suite 600, Wilmington Delaware 19801 and its mailing address is 1201 N. Market Street, Suite 111, Wilmington, DE 19801.
We expect to hold the annual shareholder’s meeting in May or June of 2023.
There are approximately 7 million adults with bipolar disorder and 680,000 suffer from either acute or sub-acute suicidal ideation. Someone in the U.S. attempts suicide every 27 seconds. Currently, there are no FDA approved medicines today focused on treatment of people with bipolar depression and acute or sub-acute suicidality.
Continental Stock Transfer & Trust Company
1 John F Kennedy Pkwy
Short Hills, NJ 07078
DLA Piper LLP
500 8th St., N.W.
Washington, DC 20004